GNRH1 and neoplasm: In general, we could clearly show that the treatment with the GnRH-III-Dau conjugates elicit a significant in vivo tumor growth inhibitory effect in all three mice models, while toxic side-effects were substantially reduced in comparison to the treatment with free Dau.